Dominick J. Angiolillo, MD, PhD

Intervention Rx

Pharmacological analysis for the practicing interventionalist.

Intervention RX

Unmet Needs in Antithrombotic Therapy for STEMI Management

Cardiology Today's Intervention, September/October 2014
Francesco Franchi, MD; Fabiana Rollini, MD; Jung Rae Cho, MD; Dominick J. Angiolillo, MD, PhD
Acute STEMI is a major cause of morbidity, mortality and disability worldwide. At present, STEMI comprises approximately 25% to 40%…
Intervention RX

Enoxaparin in Primary PCI: Insights from the ATOLL Trial

Cardiology Today's Intervention, July/August
Johanne Silvain, MD PhD; Gilles Montalescot, MD, PhD
The randomized ATOLL trial is an academic trial led by the ACTION Research group that aimed to show the superiority of enoxaparin used as an IV drug…
Intervention RX

Otamixaban: A Novel Agent Being Tested in Non-ST-Elevation ACS

Cardiology Today's Intervention, March/April
Amir-Ali Fassa, MD; P. Gabriel Steg, MD
The use of anticoagulant agents — along with antiplatelet therapy — has become the mainstay for the management of non-ST-segment…